Related Experiment Video
Updated: Nov 7, 2025

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
Published on: July 3, 2015
The μ-opioid receptor induces miR-21 expression and is ERK/PKCμ-dependent
Jen-Kuan Chang1, William D Cornwell1, Thomas J Rogers1
1Center for Inflammation, Translational and Clinical Lung Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
Abstract:
Micro RNA-21 (miR-21) is believed to perform an important role in the transition from inflammation to resolution in the innate immune response. The biochemical basis for the induction of miR-21 remains uncertain. However, the activation of the μ-opioid receptor (MOR) induces the expression of miR-21. Our results show that human monocytes treated with μ-opioid agonists exhibit a significant increase in miR-21 expression. We found that MOR-induction of miR-21 requires the activation of the Ras-Raf-MEK-ERK signaling cascade, and to our surprise, the activation of PKCμ (PKD1). These results are significant given the role of miR-21 in the sensitivity to pain.
Insights
MicroRNA-21 (miR-21) expression in monocytes is induced by the μ-opioid receptor (MOR). This process involves the Ras-Raf-MEK-ERK pathway and PKCμ (PKD1), impacting pain sensitivity.
Area of Science:
- Immunology
- Molecular Biology
- Neuroscience
Background:
- MicroRNA-21 (miR-21) is implicated in the innate immune response, particularly in the transition from inflammation to resolution.
- The precise molecular mechanisms driving miR-21 induction are not fully understood.
- Activation of the μ-opioid receptor (MOR) has been linked to increased miR-21 expression.
Purpose of the Study:
- To investigate the biochemical basis for μ-opioid receptor (MOR)-mediated induction of microRNA-21 (miR-21) expression in human monocytes.
- To identify the specific signaling pathways involved in MOR-induced miR-21 expression.
Main Methods:
- Human monocytes were treated with μ-opioid agonists.
- miR-21 expression levels were measured.
- The involvement of the Ras-Raf-MEK-ERK signaling cascade and PKCμ (PKD1) was assessed.
Main Results:
- Treatment of human monocytes with μ-opioid agonists led to a significant increase in miR-21 expression.
- MOR-induced miR-21 expression was dependent on the activation of the Ras-Raf-MEK-ERK signaling pathway.
- Activation of PKCμ (PKD1) was also found to be essential for MOR-mediated miR-21 induction.
Conclusions:
- The μ-opioid receptor (MOR) pathway, involving Ras-Raf-MEK-ERK and PKCμ (PKD1), is a key regulator of miR-21 expression in monocytes.
- These findings provide novel insights into the molecular mechanisms underlying miR-21 regulation.
- Understanding this pathway is significant for exploring the role of miR-21 in pain sensitivity and immune responses.
More Related Videos
07:30HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
Related Concept Videos
Opioid Receptors: Overview
MAPK Signaling Cascades
Analgesia and Pain Management
Regulation of the Unfolded Protein Response
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
MicroRNAs